J&J to Pay $2.2 Billion to Settle Government’s Risperdal Probe

By
-
2
105

Johnson & Johnson has agreed to pay $2.2 billion to settle probes by the U.S. government of its marketing of Risperdal and other medications, the second-largest settlement of its kind in history. Additional cases with individual states are ongoing, for which J&J is setting aside an additional $600 million.

Abstract → 

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

***

Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.

Previous articleThe NY Times: When Stimulants Are Bad
Next articleClosing Arguments Start Today in California “Zoloft Defense” Case
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

2 COMMENTS

  1. Risperdal reproached.
    Schizophrenia affects 1 percent of the world population yet I found that Zyprexa sales far exceeded that range. The saga of the schizophrenia drugs is one of incredible profit.Eli Lilly made $65 BILLION on Zyprexa franchise.
    Described as *the most successful drug in the history of neuroscience* the drugs at $12 pill are used by states to medicate deinstitutionalized mental patients to keep them out of the $500-$1000 day hospitals (*Viva Zyprexa* Lilly sales rep slogan).There is a whole underclass block of our society,including children in foster care that are the market for these drugs,but have little voice of protest if harmed by them.I am an exception,I got diabetes from Zyprexa as an off-label treatment for PTSD and I am not a mentally challenged victim so I post.
    –Daniel Haszard – FMI http://www.zyprexa-victims.com

    Report comment

    • Not only are these nasty drugs used against children in the foster care system, they’re being poked down older people in nursing homes. If you’re old and you are feisty or tend to speak out about the quality of care you’re receiving from the nurshing home, all of a sudden you end up locked in a gerry chair and drooling all over yourself in a drug-induced stupor. Problem taken care of. It’s awful.

      Report comment

LEAVE A REPLY